Novalis LifeSciences Investments I Overview
Novalis LifeSciences Investments I General Information
Description
Novalis LifeSciences Investments I is a 2019 vintage later-stage venture capital fund managed by Novalis LifeSciences. The fund is located in Hampton, New Hampshire, and invests in the United States, Canada, and Europe. The fund targets healthcare devices and supplies, pharmaceuticals and biotechnology, and life sciences sectors. The fund is a growth-oriented fund that will invest in 8-12 companies.
Contact Information
Fund Manager's Location
- 170 Commerce Way
- Suite 200
- Portsmouth, NH 03801
- United States
Novalis LifeSciences Investments I Investments (3)
Novalis LifeSciences Investments I has made a total of 3 investments. Its most recent deal was a Enko for . The deal was made on 30-Jun-2021.
withCompany Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Enko | 30-Jun-2021 | Agricultural Chemicals | Generating Revenue/Not Profitable | |||
Biotalys | 30-Jul-2019 | Agricultural Chemicals | Generating Revenue | |||
Allurion Technologies | 11-Jul-2017 | Later Stage VC (Series C) | Therapeutic Devices | Generating Revenue |
Novalis LifeSciences Investments I Investment Strategy
Novalis LifeSciences Investments I Limited Partners (1)
Louis And Anne Abrons Foundation is the sole limited partner of Novalis LifeSciences Investments I. Its latest Original was on 21-Aug-2019.
Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
---|---|---|---|---|---|
Louis And Anne Abrons Foundation | Current | 21-Aug-2019 | Original |
Novalis LifeSciences Investments I Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Novalis LifeSciences Investments I Returns History
Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
---|
Novalis LifeSciences Investments I Benchmark (607)
Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
---|---|---|---|---|---|
Endeavor Catalyst III | |||||
Pear Ventures III | 30-Jun-2022 | ||||
GSV@CS II | |||||
Mountain State Capital Fund | |||||
Cervin Ventures III Co-Invest Fund | 31-Dec-2024 | ||||
American Family Ventures Fund III | |||||
Bienville Private Opportunities Fund | |||||
Lakehouse Venture Partners Strategic Opportunities II | |||||
Quake Seed Capital Fund III | |||||
Capital Q Business Development Company |
Novalis LifeSciences Investments I FAQs
-
What is Novalis LifeSciences Investments I?
Novalis LifeSciences Investments I is a 2019 vintage later-stage venture capital fund managed by Novalis LifeSciences.
-
Who manages Novalis LifeSciences Investments I?
Novalis LifeSciences Investments I is managed by Novalis LifeSciences.
-
Where is Novalis LifeSciences Investments I domiciled?
Novalis LifeSciences Investments I is domiciled in United States: Delaware.
-
What is Novalis LifeSciences Investments I's size?
Novalis LifeSciences Investments I has a size of
. -
What type of fund is Novalis LifeSciences Investments I?
The fund type of Novalis LifeSciences Investments I is Venture.
-
What is the status of Novalis LifeSciences Investments I?
Novalis LifeSciences Investments I is closed.
-
What has Novalis LifeSciences Investments I invested in?
Novalis LifeSciences Investments I has made numerous investments in companies like Enko, Biotalys, and Allurion Technologies within the Agricultural Chemicals and Therapeutic Devices industries.
-
What has Novalis LifeSciences Investments I invested in recently?
Novalis LifeSciences Investments I's latest investment was on 30-Jun-2021 in Enko, a company within the Agricultural Chemicals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »